AbCellera Biologics Inc. Board of Directors

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Dr. Carl L.G. Hansen Ph.D.

Dr. Carl L.G. Hansen Ph.D.

CEO, President & Chairperson

Mr. Murray McCutcheon Ph.D.

Mr. Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Graham Craig M.Sc.

Graham Craig M.Sc.

Director of Corporate Development

Mr. Tryn T. Stimart Esq., J.D., M.Sc.

Mr. Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer

Marcie Thiessen CPA, CGA

Marcie Thiessen CPA, CGA

Senior Director of Finance & Accounting

Dr. Ester Falconer Ph.D.

Dr. Ester Falconer Ph.D.

Chief Technology Officer

Mr. Andrew Booth M.B.A.

Mr. Andrew Booth M.B.A.

Chief Financial Officer

Ms. Tiffany Chiu B.Sc., Ph.D.

Ms. Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.